Insider Transactions in Q1 2021 at Regenxbio Inc. (RGNX)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 25
2021
|
Kenneth T. Mills |
SELL
Open market or private sale
|
Direct |
1,500
-0.53%
|
$60,000
$40.77 P/Share
|
|
Feb 25
2021
|
Kenneth T. Mills |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+0.53%
|
$0
$0.85 P/Share
|
|
Feb 12
2021
|
Patrick J. Christmas Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
4,701
-22.31%
|
$230,349
$49.08 P/Share
|
|
Feb 12
2021
|
Patrick J. Christmas Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,701
+18.24%
|
$56,412
$12.1 P/Share
|
|
Feb 08
2021
|
Patrick J. Christmas Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,300
-7.36%
|
$63,700
$49.11 P/Share
|
|
Feb 08
2021
|
Patrick J. Christmas Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,300
+6.85%
|
$15,600
$12.1 P/Share
|
|
Feb 02
2021
|
Patrick J. Christmas Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
10,000
-19.49%
|
$440,000
$44.95 P/Share
|
|
Feb 02
2021
|
Patrick J. Christmas Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+27.49%
|
$120,000
$12.1 P/Share
|
|
Jan 25
2021
|
Kenneth T. Mills |
SELL
Open market or private sale
|
Direct |
6,500
-0.76%
|
$279,500
$43.89 P/Share
|
|
Jan 25
2021
|
Kenneth T. Mills |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+2.21%
|
$0
$0.85 P/Share
|
|
Jan 15
2021
|
Vittal Vasista Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
252
-0.22%
|
$12,600
$50.04 P/Share
|
|
Jan 14
2021
|
Vittal Vasista Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,093
-8.88%
|
$554,650
$50.03 P/Share
|
|
Jan 14
2021
|
Curran Simpson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
11,612
-39.55%
|
$580,600
$50.01 P/Share
|
|
Jan 14
2021
|
Curran Simpson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,612
+16.12%
|
$313,524
$27.65 P/Share
|
|
Jan 12
2021
|
Vittal Vasista Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,200
-3.25%
|
$210,000
$50.01 P/Share
|
|
Jan 12
2021
|
Curran Simpson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,700
-8.74%
|
$85,000
$50.03 P/Share
|
|
Jan 12
2021
|
Curran Simpson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,700
+8.04%
|
$32,300
$19.5 P/Share
|
|
Jan 12
2021
|
Patrick J. Christmas Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,378
-7.76%
|
$67,522
$49.15 P/Share
|
|
Jan 12
2021
|
Patrick J. Christmas Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,378
+7.2%
|
$26,182
$19.5 P/Share
|
|
Jan 11
2021
|
Patrick J. Christmas Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
10,122
-38.2%
|
$495,978
$49.08 P/Share
|
|
Jan 11
2021
|
Patrick J. Christmas Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,122
+16.46%
|
$151,830
$15.8 P/Share
|
|
Jan 08
2021
|
Patrick J. Christmas Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
10,000
-14.55%
|
$470,000
$47.33 P/Share
|
|
Jan 08
2021
|
Patrick J. Christmas Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+27.49%
|
$120,000
$12.1 P/Share
|
|
Jan 08
2021
|
Vittal Vasista Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,241
-1.31%
|
$246,327
$47.36 P/Share
|
|
Jan 07
2021
|
Kenneth T. Mills |
SELL
Open market or private sale
|
Direct |
1,500
-0.53%
|
$75,000
$50.01 P/Share
|
|
Jan 07
2021
|
Kenneth T. Mills |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+0.53%
|
$0
$0.85 P/Share
|
|
Jan 07
2021
|
Vittal Vasista Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,998
-7.56%
|
$549,900
$50.0 P/Share
|
|
Jan 07
2021
|
Curran Simpson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,185
-22.61%
|
$259,250
$50.01 P/Share
|
|
Jan 07
2021
|
Curran Simpson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,185
+18.44%
|
$98,515
$19.5 P/Share
|
|
Jan 04
2021
|
Kenneth T. Mills |
BUY
Grant, award, or other acquisition
|
Direct |
40,984
+12.69%
|
-
|
|
Jan 04
2021
|
Patrick J. Christmas Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,800
+45.74%
|
-
|
|
Jan 04
2021
|
Olivier Danos Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,600
+37.86%
|
-
|
|
Jan 04
2021
|
Steve Pakola Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+50.0%
|
-
|
|
Jan 04
2021
|
Curran Simpson Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,800
+43.74%
|
-
|
|
Jan 04
2021
|
Vittal Vasista Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,400
+7.86%
|
-
|